UBS Group’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $785K | Sell |
96,651
-13,566
| -12% | -$110K | ﹤0.01% | 4525 |
|
|
2025
Q1 | $776K | Buy |
110,217
+1,236
| +1% | +$8.7K | ﹤0.01% | 4382 |
|
|
2024
Q4 | $810K | Buy |
108,981
+72,890
| +202% | +$542K | ﹤0.01% | 4369 |
|
|
2024
Q3 | $178K | Buy |
36,091
+2,232
| +7% | +$11K | ﹤0.01% | 4785 |
|
|
2024
Q2 | $174K | Buy |
33,859
+9,070
| +37% | +$46.5K | ﹤0.01% | 4644 |
|
|
2024
Q1 | $132K | Sell |
24,789
-50,975
| -67% | -$271K | ﹤0.01% | 4945 |
|
|
2023
Q4 | $469K | Sell |
75,764
-5,767
| -7% | -$35.7K | ﹤0.01% | 4021 |
|
|
2023
Q3 | $615K | Buy |
81,531
+76,531
| +1,531% | +$577K | ﹤0.01% | 3466 |
|
|
2023
Q2 | $48.4K | Sell |
5,000
-26,169
| -84% | -$253K | ﹤0.01% | 5435 |
|
|
2023
Q1 | $118K | Buy |
31,169
+1,667
| +6% | +$6.29K | ﹤0.01% | 4732 |
|
|
2022
Q4 | $191K | Buy |
29,502
+6,589
| +29% | +$42.7K | ﹤0.01% | 4409 |
|
|
2022
Q3 | $204K | Sell |
22,913
-197
| -0.9% | -$1.75K | ﹤0.01% | 4044 |
|
|
2022
Q2 | $231K | Sell |
23,110
-6,511
| -22% | -$65.1K | ﹤0.01% | 3836 |
|
|
2022
Q1 | $343K | Sell |
29,621
-17,590
| -37% | -$204K | ﹤0.01% | 4006 |
|
|
2021
Q4 | $524K | Buy |
47,211
+11,971
| +34% | +$133K | ﹤0.01% | 3942 |
|
|
2021
Q3 | $325K | Buy |
35,240
+974
| +3% | +$8.98K | ﹤0.01% | 3970 |
|
|
2021
Q2 | $386K | Sell |
34,266
-10,590
| -24% | -$119K | ﹤0.01% | 3919 |
|
|
2021
Q1 | $475K | Buy |
44,856
+13,470
| +43% | +$143K | ﹤0.01% | 3969 |
|
|
2020
Q4 | $340K | Buy |
31,386
+6,088
| +24% | +$66K | ﹤0.01% | 3940 |
|
|
2020
Q3 | $246K | Sell |
25,298
-6,722
| -21% | -$65.4K | ﹤0.01% | 3871 |
|
|
2020
Q2 | $254K | Buy |
32,020
+358
| +1% | +$2.84K | ﹤0.01% | 3845 |
|
|
2020
Q1 | $275K | Sell |
31,662
-12,313
| -28% | -$107K | ﹤0.01% | 3657 |
|
|
2019
Q4 | $497K | Buy |
43,975
+10,999
| +33% | +$124K | ﹤0.01% | 3899 |
|
|
2019
Q3 | $359K | Buy |
32,976
+9,780
| +42% | +$106K | ﹤0.01% | 3959 |
|
|
2019
Q2 | $218K | Buy |
23,196
+8,754
| +61% | +$82.3K | ﹤0.01% | 4064 |
|
|
2019
Q1 | $177K | Sell |
14,442
-9,144
| -39% | -$112K | ﹤0.01% | 3931 |
|
|
2018
Q4 | $280K | Sell |
23,586
-1,768
| -7% | -$21K | ﹤0.01% | 3866 |
|
|
2018
Q3 | $365K | Buy |
25,354
+3,301
| +15% | +$47.5K | ﹤0.01% | 3844 |
|
|
2018
Q2 | $329K | Buy |
22,053
+3,340
| +18% | +$49.8K | ﹤0.01% | 3812 |
|
|
2018
Q1 | $244K | Sell |
18,713
-1,597
| -8% | -$20.8K | ﹤0.01% | 3869 |
|
|
2017
Q4 | $256K | Sell |
20,310
-1,053
| -5% | -$13.3K | ﹤0.01% | 3868 |
|
|
2017
Q3 | $277K | Buy |
21,363
+1,035
| +5% | +$13.4K | ﹤0.01% | 3823 |
|
|
2017
Q2 | $302K | Buy |
20,328
+186
| +0.9% | +$2.76K | ﹤0.01% | 3665 |
|
|
2017
Q1 | $242K | Sell |
20,142
-1,338
| -6% | -$16.1K | ﹤0.01% | 3722 |
|
|
2016
Q4 | $296K | Buy |
21,480
+6,680
| +45% | +$92.1K | ﹤0.01% | 3667 |
|
|
2016
Q3 | $198K | Sell |
14,800
-3,106
| -17% | -$41.6K | ﹤0.01% | 3740 |
|
|
2016
Q2 | $192K | Buy |
17,906
+2,262
| +14% | +$24.3K | ﹤0.01% | 3762 |
|
|
2016
Q1 | $164K | Buy |
15,644
+1,608
| +11% | +$16.9K | ﹤0.01% | 3907 |
|
|
2015
Q4 | $166K | Buy |
14,036
+2,683
| +24% | +$31.7K | ﹤0.01% | 3887 |
|
|
2015
Q3 | $132K | Buy |
11,353
+608
| +6% | +$7.07K | ﹤0.01% | 4005 |
|
|
2015
Q2 | $155K | Hold |
10,745
| – | – | ﹤0.01% | 4040 |
|
|
2015
Q1 | $150K | Sell |
10,745
-1,295
| -11% | -$18.1K | ﹤0.01% | 3961 |
|
|
2014
Q4 | $166K | Buy |
+12,040
| New | +$166K | ﹤0.01% | 3900 |
|